Terms: = Pancreatic cancer AND AFP, AFPD, FETA, HPAFP AND Staging
14 results:
1. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
2. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
Yang T; Wang N; Wang F; Liu H; Shen F; Lv G
BMJ Open; 2023 Sep; 13(9):e076467. PubMed ID: 37723113
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular Carcinoma.
Wu B; Wu Y; Guo X; Liu Y; Yue Y; Zhao W; Liu J; Wu X; Shen A; Zhang S
Med Sci Monit; 2022 Jun; 28():e937005. PubMed ID: 35726168
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy.
Mai RY; Bai T; Luo XL; Wu GB
BMC Gastroenterol; 2022 May; 22(1):261. PubMed ID: 35606690
[TBL] [Abstract] [Full Text] [Related]
7. A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.
Wang K; Xiang YJ; Yu HM; Cheng YQ; Qin YY; Wang WJ; Zhang XP; Zheng YT; Shan YF; Cong WM; Dong H; Lau WY; Cheng SQ
Eur J Surg Oncol; 2022 Jun; 48(6):1348-1355. PubMed ID: 34996665
[TBL] [Abstract] [Full Text] [Related]
8. Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.
Li M; Wang Z; Cao J; Han B; Zou H; Zang Y; Wu L
Eur J Surg Oncol; 2019 Sep; 45(9):1684-1690. PubMed ID: 31027944
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract] [Full Text] [Related]
10. Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular cancer: A Comparative Study.
Chen HY; Chen YM; Wu J; Yang FC; Lv Z; Xu XF; Zheng SS
Medicine (Baltimore); 2016 May; 95(21):e3708. PubMed ID: 27227932
[TBL] [Abstract] [Full Text] [Related]
11. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.
Toso C; Asthana S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2009 Mar; 49(3):832-8. PubMed ID: 19152426
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
[TBL] [Abstract] [Full Text] [Related]
13. Solitary pancreas metastasis from afp-producing gastric cancer: report of a case.
Natsume T; Watanabe Y; Maruyama T; Tanaka H; Shimizu T; Saito T; Kobayashi Y; Tohnosu N; Uehara T; Shimizu S; Ochiai T
Hepatogastroenterology; 2005; 52(64):1278-80. PubMed ID: 16001678
[TBL] [Abstract] [Full Text] [Related]
14. [The "false positive" tumor marker in malignant testicular tumor].
Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
[TBL] [Abstract] [Full Text] [Related]
